Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Industry Event: Innovation Theater

216: Use of a Prescription Janus Kinase (JAK) Inhibitor for Active Ankylosing Spondylitis (AS), Including Review of a Hypothetical Patient Case

Monday, November 13, 2023
10:30 AM - 11:15 AM PT
Location: Theater A

    In this session, an overview of an FDA-approved JAK inhibitor for the treatment of active AS is provided within a hypothetical patient scenario. Developed and offered by Pfizer, Inc.

    Non-CME